183 related articles for article (PubMed ID: 37146750)
1. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
Cheng C; Nguyen TT; Tang M; Wang X; Jiang C; Liu Y; Gorlov I; Gorlova O; Iafrate J; Lanuti M; Christiani DC; Amos CI
J Thorac Oncol; 2023 Sep; 18(9):1184-1198. PubMed ID: 37146750
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
Yang XR; Pi C; Zhang YC; Chen ZH; Zhang XC; Zhu DQ; Yang LL; Yin JC; Deng JY; Yang MY; Luo WC; Wu YL; Zhou Q
Mol Carcinog; 2023 Jul; 62(7):1001-1008. PubMed ID: 37067398
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma.
Zhou P; Chen D; Zhu B; Chen W; Xie Q; Wang Y; Tan Q; Yuan B; Zuo X; Huang C; Zhu H; Li G
Front Immunol; 2020; 11():594212. PubMed ID: 33552051
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
5. Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.
Zheng X; Qiu L; Huang Y; Cheng R; Huang S; Xu K; Cai W; Deng Y; Wang W; Zhong X; Cui F; Hao Z; Liu J
Mol Immunol; 2024 Apr; 168():75-88. PubMed ID: 38430689
[TBL] [Abstract][Full Text] [Related]
6. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.
Kuo CS; Liu CY; Pavlidis S; Lo YL; Wang YW; Chen CH; Ko HW; Chung FT; Lin TY; Wang TY; Lee KY; Guo YK; Wang TH; Yang CT
Front Immunol; 2018; 9():232. PubMed ID: 29483918
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non-small cell lung cancer.
Duan J; Lv G; Zhu N; Chen X; Shao Y; Liu Y; Zhao W; Shi Y
Thorac Cancer; 2022 Apr; 13(7):947-955. PubMed ID: 35150094
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
Tuminello S; Petralia F; Veluswamy R; Wang P; Flores R; Taioli E
Am J Clin Oncol; 2021 Jul; 44(7):350-355. PubMed ID: 34008498
[TBL] [Abstract][Full Text] [Related]
11. T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.
Wu L; Zhu J; Rudqvist NP; Welsh J; Lee P; Liao Z; Xu T; Jiang M; Zhu X; Pan X; Li P; Zhou Z; He X; Yin R; Feng J
Front Immunol; 2021; 12():719285. PubMed ID: 34733273
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
Benítez R; Yu K; Sirota M; Malats N; Pineda S
Front Immunol; 2023; 14():986598. PubMed ID: 36817478
[TBL] [Abstract][Full Text] [Related]
13. The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.
Öjlert ÅK; Halvorsen AR; Nebdal D; Lund-Iversen M; Solberg S; Brustugun OT; Lingjaerde OC; Helland Å
Mol Oncol; 2019 May; 13(5):1166-1179. PubMed ID: 30854794
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
[TBL] [Abstract][Full Text] [Related]
15. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
16. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Oh MS; Anker JF; Chae YK
Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
18. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
19. Characterizing heterogeneity of non-small cell lung tumour microenvironment to identify signature prognostic genes.
Mi K; Chen F; Qian Z; Chen J; Lv D; Zhang C; Xu Y; Wang H; Zhang Y; Jiang Y; Shang D
J Cell Mol Med; 2020 Dec; 24(24):14608-14618. PubMed ID: 33184998
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
